homovanillic acid has been researched along with Chronic Illness in 58 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of mianserin as a supplement in treating chronic schizophrenia was tested in 20 inpatients with schizophrenia who were receiving fixed doses of neuroleptics." | 7.68 | Effects of mianserin on negative symptoms in schizophrenia. ( Imai, T; Kai, S; Kajimura, N; Kaneyuki, H; Mizuki, Y; Suetsugi, M; Yamada, M, 1990) |
| "The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes." | 7.67 | Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986) |
| "1." | 5.29 | Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia. ( Inanaga, K; Kuniyoshi, M; Miura, C; Nakamura, J, 1994) |
| "Four patients with chronic schizophrenia of stationary character were studied in order to titrate the lowest dose of thioridazine necessary for symptomatic control when the drug is given in combination with the inhibitor of catecholamine synthesis, metyrosine." | 5.04 | Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique. ( Carlsson, A; Roos, BE; Skott, A; Wålinder, J, 1976) |
| "In order to investigate the biological mechanisms underlying the clinical efficacy of clozapine, 200 mg/day of clozapine was added to the drug regimens of 19 patients with chronic, anti-psychotic-resistant schizophrenia, and the plasma homovanillic acid (HVA), clozapine concentrations, anti-dopamine D2 and anti-serotonin 5-HT2 receptor activities were measured." | 3.69 | Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine. ( Asai, M; Fang, YY; Kanba, S; Nibuya, M; Suzuki, E; Wang, ZC; Yagi, G; Yamada, K; Yan, HG, 1996) |
| "The efficacy of mianserin as a supplement in treating chronic schizophrenia was tested in 20 inpatients with schizophrenia who were receiving fixed doses of neuroleptics." | 3.68 | Effects of mianserin on negative symptoms in schizophrenia. ( Imai, T; Kai, S; Kajimura, N; Kaneyuki, H; Mizuki, Y; Suetsugi, M; Yamada, M, 1990) |
| "Plasma homovanillic acid (pHVA) levels were measured in 16 chronically ill patients with schizophrenia who also suffered from tardive dyskinesia, and in a group of 14 chronically ill patients with schizophrenia who did not have tardive dyskinesia." | 3.68 | Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. ( Barbato, G; de Bartolomeis, A; Monteleone, P; Muscettola, G; Pickar, D, 1990) |
| "The aim of the present study was to investigate the discriminative power of a series of variables (including determination of depressive symptomatology by means of a visual analogue scale, determination of personality traits by means of the Karolinska Scales of Personality, determination of monoamine metabolites in CSF, platelet MAO activities, serum cortisol before and after dexamethasone suppression and urinary melatonin) in differentiating chronic pain patients from healthy subjects, and patients with idiopathic pain syndromes from patients with neurogenic pain syndromes." | 3.67 | Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin. ( Almay, BG; Häggendal, J; Johansson, F; Oreland, L; von Knorring, L; Wetterberg, L, 1986) |
| "In 16 patients with chronic schizophrenia, cerebrospinal fluid (CSF) concentrations of homovanillic acid (HVA) showed a significant negative correlation with computed tomographic measures of brain third ventricle size." | 3.67 | Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia. ( Bowden, CL; Contreras, SA; Houston, JP; Javors, MA; Maas, JW; McIntyre, KL, 1986) |
| " The plasma RHAL:HAL ratios on days 6 and 7 were higher than and positively correlated with those at Tmax after a single dose of HAL and were negatively correlated with the HAL:RHAL ratios at Tmax after a single dose of RHAL." | 2.66 | Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. ( Chang, WH; Chen, CT; Chen, TY; Hu, WH; Jann, MW; Lam, YW; Lin, SK; Yeh, EK, 1989) |
| "Treatment with imipramine (10mg/kg i." | 1.33 | Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. ( Antoniou, K; Bekris, S; Daskas, S; Papadopoulou-Daifoti, Z, 2005) |
| "1." | 1.29 | Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia. ( Inanaga, K; Kuniyoshi, M; Miura, C; Nakamura, J, 1994) |
| "In headache sufferers, Ac-beta-EP levels were always detectable and their mean value was significantly higher than that of healthy subjects (11." | 1.28 | Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid. ( Facchinetti, F; Genazzani, AR; Martignoni, E; Nappi, G; Pagani, I; Sances, G, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (53.45) | 18.7374 |
| 1990's | 22 (37.93) | 18.2507 |
| 2000's | 4 (6.90) | 29.6817 |
| 2010's | 1 (1.72) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, H | 1 |
| Yoshimura, R | 1 |
| Katsuki, A | 1 |
| Atake, K | 1 |
| Igata, R | 1 |
| Konishi, Y | 1 |
| Nakamura, J | 2 |
| Pacak, K | 1 |
| Tjurmina, O | 1 |
| Palkovits, M | 1 |
| Goldstein, DS | 1 |
| Koch, CA | 1 |
| Hoff, T | 1 |
| Chrousos, GP | 1 |
| Bekris, S | 1 |
| Antoniou, K | 1 |
| Daskas, S | 1 |
| Papadopoulou-Daifoti, Z | 1 |
| Tajiri, S | 1 |
| Chen, YF | 1 |
| Almay, BG | 3 |
| Johansson, F | 4 |
| von Knorring, L | 4 |
| Sedvall, G | 2 |
| Terenius, L | 2 |
| Agnoli, A | 1 |
| Ruggieri, S | 1 |
| Falaschi, P | 1 |
| Baldassarre, M | 1 |
| D'Urso, R | 1 |
| Forchetti, C | 1 |
| Polleri, A | 1 |
| Gomes, UC | 1 |
| Shanley, BC | 1 |
| Potgieter, L | 1 |
| Roux, JT | 1 |
| Gerosa, MA | 1 |
| Olivi, A | 1 |
| Longatti, PL | 1 |
| Teolato, A | 1 |
| Carteri, A | 1 |
| King, DJ | 1 |
| Cooper, SJ | 1 |
| Liddle, J | 1 |
| Bartfai, A | 1 |
| Levander, SE | 1 |
| Linnoila, M | 4 |
| Ninan, PT | 1 |
| Scheinin, M | 1 |
| Waters, RN | 1 |
| Chang, WH | 4 |
| Bartko, J | 1 |
| van Kammen, DP | 3 |
| Kuniyoshi, M | 1 |
| Miura, C | 1 |
| Inanaga, K | 1 |
| Szymanski, S | 1 |
| Lieberman, JA | 1 |
| Alvir, JM | 1 |
| Mayerhoff, D | 1 |
| Loebel, A | 1 |
| Geisler, S | 1 |
| Chakos, M | 1 |
| Koreen, A | 1 |
| Jody, D | 1 |
| Kane, J | 1 |
| Suzuki, E | 3 |
| Kanba, S | 4 |
| Nibuya, M | 3 |
| Adachi, S | 1 |
| Sekiya, U | 1 |
| Shintani, F | 2 |
| Kinoshita, N | 2 |
| Yagi, G | 4 |
| Asai, M | 3 |
| Lin, SK | 3 |
| Chung, MC | 1 |
| Lam, YW | 2 |
| Jann, MW | 3 |
| Waldo, MC | 1 |
| Cawthra, E | 1 |
| Adler, LE | 1 |
| Dubester, S | 1 |
| Staunton, M | 1 |
| Nagamoto, H | 1 |
| Baker, N | 1 |
| Madison, A | 1 |
| Simon, J | 1 |
| Scherzinger, A | 1 |
| Risby, ED | 1 |
| Jewart, RD | 1 |
| Lewine, RR | 1 |
| Risch, SC | 1 |
| Stipetic, M | 1 |
| McDaniel, JS | 1 |
| Caudle, J | 1 |
| Juang, DJ | 1 |
| Chen, LC | 1 |
| Yang, CH | 1 |
| Lane, HY | 1 |
| Prell, GD | 1 |
| Green, JP | 1 |
| Elkashef, AM | 1 |
| Khandelwal, JK | 1 |
| Wyatt, RJ | 1 |
| Lawson, WB | 1 |
| Jaeger, AC | 1 |
| Kaufmann, CA | 1 |
| Kirch, DG | 1 |
| Fukuda, M | 1 |
| Niwa, S | 1 |
| Hiramatsu, K | 1 |
| Hata, A | 1 |
| Nakagome, K | 1 |
| Iwanami, A | 1 |
| Honda, H | 1 |
| Kelley, ME | 1 |
| Yao, JK | 1 |
| Gilbertson, MW | 1 |
| Gurklis, JA | 1 |
| Inosaka, T | 1 |
| Saito, H | 1 |
| Peters, JL | 1 |
| Sato, M | 2 |
| Yamada, K | 2 |
| Ohnishi, K | 1 |
| Ashikari, I | 1 |
| Wang, ZC | 1 |
| Fang, YY | 1 |
| Yan, HG | 1 |
| Pestana, M | 1 |
| Jardim, H | 1 |
| Serrão, P | 1 |
| Soares-da-Silva, P | 1 |
| Guerra, L | 1 |
| Spivak, B | 1 |
| Vered, Y | 1 |
| Graff, E | 1 |
| Blum, I | 1 |
| Mester, R | 1 |
| Weizman, A | 1 |
| Hildebrand, BE | 1 |
| Svensson, TH | 1 |
| Nagao, T | 1 |
| Ohshimo, T | 1 |
| Mitsunobu, K | 1 |
| Otsuki, S | 1 |
| Wålinder, J | 2 |
| Skott, A | 2 |
| Carlsson, A | 2 |
| Roos, BE | 2 |
| Bowers, MB | 1 |
| Subrahmanyam, S | 1 |
| Facchinetti, F | 1 |
| Sances, G | 1 |
| Martignoni, E | 1 |
| Pagani, I | 1 |
| Nappi, G | 1 |
| Genazzani, AR | 1 |
| Davidson, M | 4 |
| Kahn, RS | 2 |
| Powchik, P | 1 |
| Warne, P | 1 |
| Losonczy, MF | 2 |
| Kaminsky, R | 2 |
| Apter, S | 2 |
| Jaff, S | 1 |
| Davis, KL | 4 |
| Koshikawa, H | 1 |
| Ishizuki, T | 1 |
| Kohno, H | 1 |
| Nakaki, T | 1 |
| Houvenagel, E | 1 |
| Forzy, G | 1 |
| Leloire, O | 1 |
| Gallois, P | 1 |
| Hary, S | 1 |
| Hautecoeur, P | 1 |
| Convain, L | 1 |
| Henniaux, M | 1 |
| Vincent, G | 1 |
| Dhondt, JL | 1 |
| Mizuki, Y | 1 |
| Kajimura, N | 1 |
| Imai, T | 1 |
| Suetsugi, M | 1 |
| Kai, S | 1 |
| Kaneyuki, H | 1 |
| Yamada, M | 1 |
| Knott, P | 1 |
| Cooper, M | 1 |
| DuMont, K | 1 |
| Breier, A | 1 |
| Wolkowitz, OM | 1 |
| Roy, A | 2 |
| Potter, WZ | 1 |
| Pickar, D | 4 |
| Muscettola, G | 1 |
| Barbato, G | 1 |
| de Bartolomeis, A | 1 |
| Monteleone, P | 1 |
| Ninan, P | 1 |
| Mazonson, A | 1 |
| Van Kammen, D | 1 |
| Paul, SM | 1 |
| Sakurada, T | 1 |
| Oreland, L | 2 |
| Häggendal, J | 2 |
| Magnusson, T | 1 |
| Almay, B | 1 |
| Song, IS | 1 |
| Mohs, RC | 1 |
| Mathé, AA | 1 |
| Davis, BM | 1 |
| Wetterberg, L | 1 |
| France, RD | 1 |
| Urban, BJ | 1 |
| Pelton, S | 1 |
| Kilts, CD | 1 |
| Hong, JS | 1 |
| Nemeroff, CB | 1 |
| Peters, J | 1 |
| van Kammen, WB | 1 |
| Nugent, A | 1 |
| Goetz, KL | 1 |
| Yao, J | 1 |
| Dávila, R | 1 |
| Bagdy, G | 2 |
| Perényi, A | 2 |
| Frecska, E | 2 |
| Révai, K | 2 |
| Papp, Z | 1 |
| Fekete, MI | 1 |
| Arató, M | 1 |
| Chen, TY | 1 |
| Chen, CT | 1 |
| Hu, WH | 1 |
| Yeh, EK | 1 |
| Heh, CW | 1 |
| Potkin, SG | 1 |
| Costa, J | 1 |
| Herrera, J | 1 |
| Sramek, J | 1 |
| DeMet, E | 1 |
| Contreras, SA | 2 |
| Maas, JW | 2 |
| Seleshi, E | 1 |
| Bowden, CL | 2 |
| Cabib, S | 1 |
| Kempf, E | 1 |
| Schleef, C | 1 |
| Mele, A | 1 |
| Puglisi-Allegra, S | 1 |
| Houston, JP | 1 |
| McIntyre, KL | 1 |
| Javors, MA | 1 |
| Sonninen, V | 1 |
| Riekkinen, P | 1 |
| Rinne, UK | 1 |
| Wright, JT | 1 |
| Das, AK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Trial Administering Estradiol Patch vs. Placebo Patch as add-on to Antipsychotics in Female Patients Above the Age of 38 With Schizophrenia, Schizoaffective or Schizophreniform Disorder[NCT04093518] | Phase 3 | 100 participants (Anticipated) | Interventional | 2019-12-02 | Recruiting | ||
| Hypoalgesic Effects of Specific vs Non-specific Cervical Manipulation in Healthy Subjects[NCT03541538] | 21 participants (Actual) | Interventional | 2018-06-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for homovanillic acid and Chronic Illness
| Article | Year |
|---|---|
[Vanillylmandelic acid (VMA) and homovanillic acid (HVA)].
Topics: Adrenal Gland Neoplasms; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Depressi | 2005 |
6 trials available for homovanillic acid and Chronic Illness
| Article | Year |
|---|---|
The effect of propranolol on CSF amine metabolites in psychiatric patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Glycols; Homovanillic Acid; Humans; Hydrox | 1983 |
Predicting haloperidol treatment response in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyh | 1996 |
Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; | 1976 |
Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
Topics: Antipsychotic Agents; Benzazepines; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Male; M | 1991 |
Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients.
Topics: Adult; Biological Availability; Brain; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Male | 1989 |
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Apomorphine; Chronic Disease; Clinical Trials as Topic; Diben | 1988 |
51 other studies available for homovanillic acid and Chronic Illness
| Article | Year |
|---|---|
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Topics: Adult; Antipsychotic Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Case-Control Studies; Ch | 2017 |
Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Chronic Disea | 2002 |
Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Beh | 2005 |
[Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Topics: Adult; Antipsychotic Agents; Biogenic Amines; Chronic Disease; Female; Homovanillic Acid; Humans; Hy | 1984 |
Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients.
Topics: Adult; Aged; Biogenic Amines; Chronic Disease; Endorphins; Female; Homovanillic Acid; Humans; Hydrox | 1980 |
A neuropharmacological and neuroendocrine study on idiopathic and chronic pharmacological Parkinsonism.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Circadian Rhythm; Homovanillic Acid; Humans; Hyd | 1980 |
Noradrenergic overactivity in chronic schizophrenia: evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations.
Topics: Adult; Chronic Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Ag | 1980 |
Cerebrospinal fluid levels of cyclic nucleotides and monoaminergic metabolites in subarachnoid haemorrhage: preliminary report.
Topics: Acute Disease; Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Female; Homovanillic Acid; Humans; Hy | 1981 |
Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Eye Movements; Female; Galvanic Skin Response; Habitua | 1983 |
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
Topics: Adult; Chronic Disease; Female; Glycols; Homovanillic Acid; Hospitalization; Humans; Hydroxyindoleac | 1983 |
Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
Topics: Adult; Biogenic Monoamines; Chronic Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1994 |
Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Chronic Disease; Female; Follow-Up Studies; H | 1995 |
Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Arousal; Chronic Disease; Homovanillic Acid; Hospitalization; Humans; L | 1994 |
Disposition of clozapine and desmethylclozapine in schizophrenic patients.
Topics: Adult; Chronic Disease; Clozapine; Dextromethorphan; Half-Life; Homovanillic Acid; Humans; Male; Met | 1994 |
Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.
Topics: Acoustic Stimulation; Adult; Amygdala; Arousal; Attention; Catecholamines; Chronic Disease; Dopamine | 1994 |
An association between increased concentrations of cerebrospinal fluid dopamine sulfate and higher negative symptom scores in patients with schizophrenia and schizoaffective disorder.
Topics: Chronic Disease; Dopamine; Homovanillic Acid; Humans; Psychiatric Status Rating Scales; Psychotic Di | 1993 |
Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients.
Topics: Adult; Brain; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Homovanillic Acid; | 1993 |
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Biogenic Amines; Chronic Disease; Drinking; Female; Histamine | 1996 |
Exaggerated responsivity of brain dopaminergic system activity in schizophrenia: a preliminary finding of increased variance of plasma homovanillic acid level in a chronic patient.
Topics: Adult; Brain; Chronic Disease; Dopamine; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyi | 1996 |
Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
Topics: Adult; Aged; Amantadine; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Ad | 1997 |
Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clozapine; Dopamine; Homovanillic Acid; Humans; Male; | 1996 |
Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Biopsy; Catechol O-Methyltransferase; Chromatography, H | 1998 |
Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder.
Topics: Adult; Anxiety; Biomarkers; Case-Control Studies; Chronic Disease; Combat Disorders; Dopamine; Homov | 1999 |
Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chronic Disease; Dopamine; Extracellular | 2000 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Ho | 1979 |
CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Bipolar Disorder; Chronic Disease; Female; Homovanillic Acid; Huma | 1976 |
Role of biogenic amines in certain pathological conditions.
Topics: Acute Disease; Adult; Aggression; Biogenic Amines; Bipolar Disorder; Chlorpromazine; Chronic Disease | 1975 |
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid.
Topics: Adult; Aged; beta-Endorphin; Chromatography, High Pressure Liquid; Chronic Disease; Female; Headache | 1992 |
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Homovanillic Acid; Humans; Psychiatric Statu | 1991 |
[Cerebrospinal fluid monoamines in primary fibromyalgia].
Topics: Adult; Chronic Disease; Dopamine; Female; Fibromyalgia; Homovanillic Acid; Humans; Hydroxyindoleacet | 1990 |
Effects of mianserin on negative symptoms in schizophrenia.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chronic Disease; Drug Therapy, Combination | 1990 |
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
Topics: Administration, Oral; Adult; Chronic Disease; Depression, Chemical; Dopamine; Dopamine Antagonists; | 1991 |
Plasma norepinephrine in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Homovanillic Acid; Humans; Male; Norepinephrine; Posture; Psychiatri | 1990 |
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
Topics: Aged; Chronic Disease; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; Middle Aged; Neuro | 1990 |
CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
Topics: Adult; Chronic Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1985 |
Long-term high frequency transcutaneous electrical nerve stimulation (hi-TNS) in chronic pain. Clinical response and effects on CSF-endorphins, monoamine metabolites, substance P-like immunoreactivity (SPLI) and pain measures.
Topics: Adult; Aged; Chronic Disease; Electric Stimulation Therapy; Endorphins; Female; Follow-Up Studies; G | 1985 |
Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.
Topics: Age Factors; Blood Platelets; Body Height; Chronic Disease; Female; Homovanillic Acid; Humans; Hydro | 1986 |
Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
Topics: Adult; Apomorphine; Brain; Cerebral Ventricles; Chronic Disease; Growth Hormone; Homovanillic Acid; | 1986 |
Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.
Topics: Adult; Chronic Disease; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydr | 1986 |
CSF monoamine metabolites in chronic pain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Back Pain; Biogenic Amines; Chronic Disease; Depressive | 1987 |
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans | 1989 |
Plasma HVA, neuroleptics, and dopaminergic plasticity.
Topics: Antipsychotic Agents; Brain; Chronic Disease; Homovanillic Acid; Humans; Neuronal Plasticity; Recept | 1989 |
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Female; Halo | 1985 |
CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Brain; Chronic Disease; Dopamine; Femal | 1985 |
Serum homovanillic acid concentrations in carbamazepine-treated chronic schizophrenics.
Topics: Adult; Carbamazepine; Chronic Disease; Homovanillic Acid; Humans; Male; Receptors, Dopamine; Schizop | 1989 |
Different effects of acute and chronic stress on two dopamine-mediated behaviors in the mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Animals; Apomorphine; Brain; Caudate Nucleus; Chronic | 1988 |
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
Topics: Adult; Brain; Chronic Disease; Circadian Rhythm; Dopamine; Homovanillic Acid; Hospitalization; Human | 1988 |
Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
Topics: Adult; Atrophy; Brain; Cerebral Ventricles; Chronic Disease; Female; Homovanillic Acid; Humans; Male | 1986 |
Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.
Topics: Chronic Disease; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hyd | 1973 |
Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
Topics: Acute Disease; Adult; Brain; Chronic Disease; Demyelinating Diseases; Female; Homovanillic Acid; Hum | 1973 |
Urinary excretion of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in patients with diarrhoea of presumed nervous origin.
Topics: Adult; Aged; Anxiety; Chronic Disease; Circadian Rhythm; Diarrhea; Female; Homovanillic Acid; Humans | 1973 |